BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Praecis Pharmaceuticals Inc

About Praecis Pharmaceuticals Inc

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies to address significant unmet medical needs. In the United States PRAECIS has received FDA approval to market Plenaxis® (abarelix for injectable suspension).

Two of their programs have moved beyond the research phase and into clinical testing:

Apan™ for Alzheimer's Disease

PPI-2458 for Non-Hodgkin's Lymphoma

In addition, Praecis has a number of research programs focused on developing therapies to treat rheumatoid arthritis, certain types of cancer, and other diseases.

 

 

PRODUCT PIPELINE

Apan™ for Alzheimer's Disease

PPI-2458 for Non-Hodgkin's Lymphoma/ Arthritis

 

Home Page

Key Statistics for Praecis

Basic Chart for Praecis

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com